Discover
KROS
Keros Therapeutics, Inc.
10.88
2 x 7.76
2 x 13.65
bid
ask
+
0.18
1.68%
2 @ 04:00 PM
10.88 +0.00 (0.00%)
| Ytd | -46.56% | |
| 1y | -18.44% |
10.60
day range
10.94
9.69
52 week range
22.55
| Open | 10.70 | Prev Close | 10.70 | Low | 10.60 | High | 10.94 | Mkt Cap | 215.34M |
| Vol | 209.95K | Avg Vol | 324.86K | EPS | -2.53 | P/E | N/A | Forward P/E | -3.00 |
| Beta | 1.24 | Short Ratio | 5.28 | Inst. Own | 100.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 10.96 | 200-d Avg | 14.78 | 1yr Est | 43.55 |
| Income Statement | |||
| Total Revenue | 367.00K | ||
| Revenues (USD) | 367.00K | ||
| Gross Profit | 367.00K | ||
| Operating Expenses | 26.24M | ||
| Research and Development Expense | 16.10M | ||
| Selling, General and Administrative Expense | 10.15M | ||
| Operating Income | -25.88M | ||
| Net Income | -23.71M | ||
| Net Income Common Stock | -23.71M | ||
| Net Income Common Stock (USD) | -23.71M | ||
| Consolidated Income | -23.71M | ||
| Earnings per Basic Share | -1.21 | ||
| Earnings per Basic Share (USD) | -1.21 | ||
| Earnings per Diluted Share | -1.21 | ||
| Earning Before Interest & Taxes (EBIT) | -23.71M | ||
| Earning Before Interest & Taxes (USD) | -23.71M | ||
| Weighted Average Shares | 19.63M | ||
| Weighted Average Shares Diluted | 19.63M | ||
| Balance Sheet | |||
| Cash and Equivalents | 282.95M | ||
| Cash and Equivalents (USD) | 282.95M | ||
| Trade and Non-Trade Receivables | 400.00K | ||
| Current Assets | 290.68M | ||
| Property, Plant & Equipment Net | 20.17M | ||
| Total Assets | 312.29M | ||
| Debt Current | 2.50M | ||
| Total Debt | 16.31M | ||
| Current Liabilities | 12.85M | ||
| Debt Non-Current | 13.81M | ||
| Total Liabilities | 26.66M | ||
| Accumulated Retained Earnings (Deficit) | -505.47M | ||
| Shareholders Equity | 285.63M | ||
| Shareholders Equity (USD) | 285.63M | ||
| Assets Non-Current | 21.62M | ||
| Total Debt (USD) | 16.31M | ||
| Liabilities Non-Current | 13.81M | ||
| Trade and Non-Trade Payables | 1.49M | ||
| Tax Assets | 2.25M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.04M | ||
| Net Cash Flow from Financing | -2.32M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.92M | ||
| Capital Expenditure | -73.00K | ||
| Issuance (Purchase) of Equity Shares | 7.00K | ||
| Net Cash Flow from Investing | -73.00K | ||
| Net Cash Flow from Operations | -3.53M | ||
| Share Based Compensation | 6.20M | ||